Validation Rules as a First Step for Data Quality: Pharmacovigilance Application in Portugal
Studies in Health Technology and Informatics · 18.05.2023
DOI: 10.3233/shti230151 ↗Kurz gefasst
Fachartikel in der Zeitschrift Studies in Health Technology and Informatics, erschienen am 18.05.2023. Verfasst von Bárbara Costa und 2 weiteren Autor:innen. Beteiligte Einrichtung: CINTESIS, Faculty of Medicine, University of Porto, Portugal. Hauptthemen laut MEDLINE: Pharmacovigilance, Drug-Related Side Effects and Adverse Reactions. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Tracking and reporting Adverse Drug Reactions (ADRs) is crucial for patient safety. This work aims to improve the data quality of the SIRAI application in Portugal by developing data validation rules and a scoring system for each record and the overall dataset. The goal is to enhance the effectiveness of the SIRAI application in monitoring adverse drug reactions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- CINTESIS, Faculty of Medicine, University of Porto, Portugal.
- MEDCIDS, Faculty of Medicine, University of Porto, Portugal.
- Public Health Unit, Matosinhos Local Health Unit, Matosinhos, Portugal.
Zitieren
APA
Costa, B., Figueiredo, B., & Pinheiro, V. (2023). Validation Rules as a First Step for Data Quality: Pharmacovigilance Application in Portugal. Studies in Health Technology and Informatics. https://doi.org/10.3233/shti230151
Vancouver
Costa B, Figueiredo B, Pinheiro V. Validation Rules as a First Step for Data Quality: Pharmacovigilance Application in Portugal. Studies in Health Technology and Informatics. 2023. doi:10.3233/shti230151
BibTeX
@article{Costa2023,
author = {Costa, Bárbara and Figueiredo, Bruno and Pinheiro, Vera},
title = {Validation Rules as a First Step for Data Quality: Pharmacovigilance Application in Portugal},
journal = {Studies in Health Technology and Informatics},
year = {2023},
doi = {10.3233/shti230151}
}
EUVIMED